Commentary: Apples to oranges: Individualized approach in aortic stenosis with coronary artery disease requires careful comparison and granular data

Although the exact prevalence ranges widely due to variable definitions and populations of interest, the presence of coronary artery disease (CAD) in patients with severe aortic stenosis (AS) is not uncommon.1 Great strides have been made in determining the benefit of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in various patient populations,2,3 and it is due time to parse out the ideal management of patients requiring concomitant or staged procedures for severe AS with significant CAD.